Patient Characteristics and Elranatamab administration patterns of Real-World Patients Receiving Elranatamab

05/05/2026
22/07/2026
EU PAS number:
EUPAS1000000853
Study
Planned
Subscribe
Download as PDF
Study type

Study type

Non-interventional study
Non-interventional study
No information provided.
Study drug and medical condition
No information provided.
Population studied
No information provided.
Study design details
No information provided.